Behavioral Health and Substance Dependence

Drug Seeking Behavior in ER Doubles

Catasys Health - Thursday, October 28, 2010

Drug Seeking Behavior in ER Doubles, Feeds Growing Addiction to Pain Pills -- Emergency rooms continue to become a major resource for pain medication addicts; By MIKAELA CONLEY, ABC News Medical Unit -- Oct. 28, 2010 » More

Comments (0) | Trackbacks (0) | Permalink

Hospitalizations for Drug Use Up Dramatically

Catasys Health - Wednesday, October 27, 2010

Cheryl Clark, for HealthLeaders Media, October 27, 2010
Medication and illegal drug-related problems put twice as many middle-aged and older Americans in the hospital in 2008 as in 1997, according to a report from the Agency for Healthcare Research and Quality. » More

Comments (0) | Trackbacks (0) | Permalink

FDA Approves Vivitrol to Treat Opioid Dependence

Catasys Health - Friday, October 15, 2010

The Food and Drug Administration, FDA, has approved the drug Vivitrol for the treatment of opioid dependence according to a news release by them on 10-12-2010. The National Institute on Drug Abuse says that about 810,000 people are addicted to heroin, and 1.85 million to painkillers like OxyContin. The numbers are probably much higher than this, however. You can read the full article at examiner.com » More

Comments (0) | Trackbacks (0) | Permalink

Catasys Launches OnTrak™ Facebook Page

Catasys Health - Monday, January 04, 2010

Check out our new Catasys Health Facebook Recovery Network http://www.facebook.com/stayontrak. Also, don't forget to Like our Facebook Health Care Page.

Social Media Philosophy - Lead the social media revolution in Substance Dependence and Behavioral Health Care, contributing to health and well being for families and friends everywhere.

» More

Comments (0) | Trackbacks (0) | Permalink

Cutting Edge Treatment for Substance Dependence for Health Plans

Catasys Health - Wednesday, December 16, 2009

For every 1 million members in a health plan, approximately $160 million in claims are incurred by members diagnosed with Substance Dependence. Most health plans have realistic cost savings opportunities in the millions of dollars. Our Medical Economics group can demonstrate specific savings opportunities for health plans with respect to both medical and behavioral costs.  The OnTrak program addresses many of the challenges experts highlight within the existing treatment paradigm for substance dependence. Specifically, OnTrak: » More

Comments (0) | Trackbacks (0) | Permalink

Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy of Flumazenil and Gabapentin in Reducing Craving and Use During use during Initial Treatment of Methamphetamine Dependence

Catasys Health - Wednesday, November 25, 2009

Harold Urschel, Research Across America, Dallas, Texas
Published in the Journal of Psychopharmacology, November 25, 2009
» More

Comments (0) | Trackbacks (0) | Permalink